首页> 外文期刊>细胞研究(英文版) >Structure of the receptor-activated human TRPC6 and TRPC3 ion channels
【24h】

Structure of the receptor-activated human TRPC6 and TRPC3 ion channels

机译:受体激活的人类TRPC6和TRPC3离子通道的结构

获取原文
获取原文并翻译 | 示例
       

摘要

TRPC6 and TRPC3 are receptor-activated nonselective cation channels that belong to the family of canonical transient receptor potential (TRPC) channels. They are activated by diacylglycerol, a lipid second messenger. TRPC6 and TRPC3 are involved in many physiological processes and implicated in human genetic diseases. Here we present the structure of human TRPC6 homotetramer in complex with a newly identified high-affinity inhibitor BTDM solved by single-particle cryo-electron microscopy to 3.8 A resolution. We also present the structure of human TRPC3 at 4.4 A resolution. These structures show two-layer architectures in which the bell-shaped cytosolic layer holds the transmembrane layer. Extensive inter-subunit interactions of cytosolic domains, including the N-terminal ankyrin repeats and the C-terminal coiled-coil, contribute to the tetramer assembly. The high-affinity inhibitor BTDM wedges between the S5-S6 pore domain and voltage sensor-like domain to inhibit channel opening. Our structures uncover the molecular architecture of TRPC channels and provide a structural basis for understanding the mechanism of these channels.
机译:TRPC6和TRPC3是受体激活的非选择性阳离子通道,属于规范的瞬态受体电位(TRPC)通道家族。它们被脂质第二信使二酰基甘油激活。 TRPC6和TRPC3涉及许多生理过程,并与人类遗传疾病有关。在这里,我们介绍了人类TRPC6同四聚体的结构,该结构与新鉴定的高亲和力抑制剂BTDM结合,可通过单粒子冷冻电子显微镜解决3.8 A的分辨率。我们还以4.4 A的分辨率展示了人类TRPC3的结构。这些结构显示了两层结构,其中钟形的胞质层保持跨膜层。胞质域的广泛的亚基间相互作用,包括N末端锚蛋白重复和C末端卷曲螺旋,有助于四聚体组装。高亲和力抑制剂BTDM楔入S5-S6孔结构域和电压传感器样结构域之间,以抑制通道打开。我们的结构揭示了TRPC通道的分子结构,并为理解这些通道的机理提供了结构基础。

著录项

  • 来源
    《细胞研究(英文版)》 |2018年第7期|746-755|共10页
  • 作者单位

    State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, 100871 Beijing, China;

    State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, 100871 Beijing, China;

    Dizal Pharmaceutical Company, Jiangsu, China;

    State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, 100871 Beijing, China;

    Peking-Tsinghua Center for Life Sciences, Peking University, 100871 Beijing, China;

    Dizal Pharmaceutical Company, Jiangsu, China;

    Dizal Pharmaceutical Company, Jiangsu, China;

    Dizal Pharmaceutical Company, Jiangsu, China;

    State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, 100871 Beijing, China;

    Peking-Tsinghua Center for Life Sciences, Peking University, 100871 Beijing, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 04:01:41
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号